ADVERUM BIOTECHNOLOGIES INC
COM · CUSIP 00773U108
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Implied quarter-end price ≈ $14.14.
Trends to Q1 2024
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q3 2022 | 79 |
| Q4 2022 | 60 |
| Q1 2023 | 56 |
| Q2 2023 | 59 |
| Q3 2023 | 62 |
| Q4 2023 | 62 |
| Q1 2024 | 3 |
Buyers vs sellers
Managers adding to or starting a position, vs cutting or selling out
Numbers
| Quarter | Bought or added | Cut or sold out |
|---|---|---|
| Q4 2022 | 19 | 47 |
| Q1 2023 | 20 | 26 |
| Q2 2023 | 20 | 29 |
| Q3 2023 | 25 | 28 |
| Q4 2023 | 25 | 25 |
| Q1 2024 | 2 | 62 |
Calls vs puts
Options held, notional value, last 4 quarters. P/C = puts ÷ calls
Numbers
| Quarter | Calls | Puts | P/C |
|---|---|---|---|
| Q2 2023 | $125.0k | $0 | 0.00 |
| Q3 2023 | $419.7k | $300 | 0.00 |
| Q4 2023 | $42.4k | $3.0k | 0.07 |
| Q1 2024 | $0 | $0 | — |
Biggest buyers
| TCG Crossover Management, LLC | New | +2.0m |
| Frazier Life Sciences Management, L.P. | New | +1.1m |
Biggest sellers
| MORGAN STANLEY | Sold out | -10.3m |
| Commodore Capital LP | Sold out | -10.0m |
| FMR LLC | Sold out | -6.1m |
| Venrock Adviser, LLC | Sold out | -5.1m |
| Versant Venture Management, LLC | Reduced | -4.6m |
| BML Capital Management, LLC | Sold out | -4.6m |
| GOLDMAN SACHS GROUP INC | Sold out | -4.6m |
| BANK OF AMERICA CORP /DE/ | Sold out | -4.3m |
| VANGUARD GROUP INC | Sold out | -4.2m |
| AIGH Capital Management LLC | Sold out | -3.2m |
Major shareholders (over 5%)
Anyone who owns more than 5% of a class of the company's shares has to say so: on Schedule 13D if they may try to influence or control the company, on 13G if they're a passive investor, and update it as the stake changes. Each holder's latest filing, from 19 Dec 2024 on; percentages are of the share class, as the holder worked them out.
| Holder | Stake |
|---|---|
| TCG Crossover GP II, LLC 13G · passive investor filed 2025-05-15 | 8.9% |
Fell to 5% or below in the last year: BML Investment Partners, L.P. (0.0%, 2025-12-09)
Holders, Q1 2024
| Manager | Shares | Change |
|---|---|---|
| TCG Crossover Management, LLC 2.25% of their portfolio | 2.0m $28.4m | New |
| Frazier Life Sciences Management, L.P. 0.64% of their portfolio | 1.1m $15.1m | New |
| Versant Venture Management, LLC 6.95% of their portfolio | 506.8k $7.2m | Reduced -4.6m |